Your chance to invest in a potential vaccine for Covid-19
It’s not everyday that you get the chance to invest in a potentially world-changing piece of research. Ruti Immune is not developing a new antibody or T-cell specific vaccine (like the Oxford University vaccine and others), but is testing whether a vaccine designed for tuberculosis could help build “innate immunity” from Covid-19 and other viral infections. The Ruti Immune’s clinical trial will test the hypothesis that innate immunity can complement Covid-19 specific vaccines to bolster resistance to the virus. If this hypothesis is proven, Ruti Immune will need to prove that the RUTI® vaccine is the best-in-class to build innate immunity. What is for sure, however, is that crowdfunding investors could cash in bigtime, if the RUTI® vaccine is shown to be fit for the fight.